Thomas Stankovich insider trades: ReShape Lifesciences (RSLS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
29 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 31, 2024 | RSLS | ↓ Sell | 172 | $0.23 | $39 | Direct | Aug 13, 2024 (74d) |
| Oct 25, 2023 | RSLS | ↓ Sell | 435 | $0.89 | $386 | Direct | Nov 8, 2023 (14d) |
| Jul 6, 2023 | RSLS | ↓ Sell | 106 | $1.47 | $156 | Direct | Jul 19, 2023 (13d) |
| Jun 30, 2023 | RSLS | ↑ Buy | 17,702 | $1.52 | $27K | Direct | Jul 6, 2023 (6d) |
| May 31, 2023 | RSLS | ↓ Sell | 303 | $2.46 | $746 | Direct | Jul 6, 2023 (36d) |
| Feb 28, 2023 | RSLS | ↓ Sell | 418 | $8.87 | $4K | Direct | Mar 7, 2023 (7d) |
| Dec 1, 2022 | RSLS | ↓ Sell | 372,113 | $0.17 | $63K | Direct | Dec 20, 2022 (19d) |
| Nov 4, 2022 | RSLS | ↓ Sell | 8,393 | $0.27 | $2K | Direct | Nov 10, 2022 (6d) |
| Oct 4, 2022 | RSLS | ↓ Sell | 8,293 | $0.28 | $2K | Direct | Oct 6, 2022 (2d) |
| Sep 6, 2022 | RSLS | ↓ Sell | 4,828 | $0.39 | $2K | Direct | Sep 12, 2022 (6d) |
| Aug 5, 2022 | RSLS | ↓ Sell | 4,728 | $0.47 | $2K | Direct | Aug 11, 2022 (6d) |
| Jul 1, 2022 | RSLS | ↓ Sell | 4,630 | $0.55 | $3K | Direct | Jul 6, 2022 (5d) |
| Jun 1, 2022 | RSLS | ↓ Sell | 4,478 | $0.96 | $4K | Direct | Jun 6, 2022 (5d) |
| May 31, 2022 | RSLS | ↑ Buy | 20,000 | $0.92 | $18K | Direct | Jun 1, 2022 (1d) |
| May 5, 2022 | RSLS | ↓ Sell | 4,529 | $0.77 | $3K | Direct | May 12, 2022 (7d) |
| Apr 1, 2022 | RSLS | ↓ Sell | 5,038 | $1.13 | $6K | Direct | Apr 8, 2022 (7d) |
| Feb 28, 2022 | RSLS | ↓ Sell | 3,658 | $1.06 | $4K | Direct | Mar 2, 2022 (2d) |
| Jan 31, 2022 | RSLS | ↓ Sell | 3,684 | $1.22 | $4K | Direct | Feb 2, 2022 (2d) |
| Jan 4, 2022 | RSLS | ↓ Sell | 3,171 | $1.78 | $6K | Direct | Jan 28, 2022 (24d) |
| Dec 2, 2021 | RSLS | ↓ Sell | 4,304 | $1.83 | $8K | Direct | Dec 9, 2021 (7d) |
| Nov 18, 2021 | RSLS | ↑ Buy | 20,000 | $2.02 | $40K | Direct | Nov 18, 2021 (0d) |
| Nov 2, 2021 | RSLS | ↓ Sell | 4,320 | $2.69 | $12K | Direct | Nov 16, 2021 (14d) |
| Oct 1, 2021 | RSLS | ↓ Sell | 3,660 | $2.76 | $10K | Direct | Oct 12, 2021 (11d) |
| Sep 10, 2021 | RSLS | ↓ Sell | 48,366 | $2.89 | $140K | Direct | Sep 17, 2021 (7d) |
| Aug 30, 2021 | RSLS | ↑ Buy | 15,000 | $3.43 | $51K | Direct | Aug 31, 2021 (1d) |
| Aug 20, 2021 | RSLS | ↑ Buy | 15,000 | $3.22 | $48K | Direct | Aug 24, 2021 (4d) |
| Sep 16, 2020 | RSLS | ↑ Buy | 530 | $3.00 | $2K | Direct | Sep 17, 2020 (1d) |
| Aug 19, 2020 | RSLS | ↑ Buy | 4,105 | $3.00 | $12K | Direct | Aug 20, 2020 (1d) |
| Dec 14, 2009 | RGDX | ↑ Buy | 7,000 | $1.35 | $9K | Direct | Dec 14, 2009 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Thomas Stankovich's insider trades
Thomas Stankovich is Chief Financial Officer at ReShape Lifesciences (RSLS). Since Dec 14, 2009, Thomas has reported 8 open-market purchases worth $209K and 21 sales worth $276K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), other transactions (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RSLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.